Establishing a cycle development strategy that fulfills regulatory requirements
A painless look inside the most impactful regulatory trends and actions from 2017
FDA aims to make its risk evaluation and mitigation strategy easier, and changes are in the works to help manufacturers meet the required safety measures
Asset intelligence gives cGMP manufacturers a new way to harness the information they need to prove manufacturing compliance
White Papers: In Depth Research
Posted: Jan 06, 2015
The Best of Pharmaceutical Manufacturing eBook is a collection of the most-read feature articles from 2014, chosen by the Pharmaceutical Manufacturing digital audience.